Warby Parker (WRBY) Liabilities and Shareholders Equity (2020 - 2026)

Warby Parker (WRBY) reported Liabilities and Shareholders Equity of $736.4 million for Q1 2026, up 7.86% on a YoY basis from $682.8 million in Q1 2025, and up 2.15% quarter-over-quarter from $720.9 million in Q4 2025.

Warby Parker (WRBY) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Warby Parker has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $736.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 7.86% year-over-year to $736.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.9 billion (up 9.59% YoY), and the FY2025 full-year result was $720.9 million, up 6.57% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $736.4 million, up from $720.9 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $736.4 million in Q1 2026, with the low at $543.6 million in Q2 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $621.0 million across 5 years, with a median of $592.9 million in 2024.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity grew 29.06% — and 2023, when it rose 2.04%.
  • Warby Parker's Liabilities and Shareholders Equity stood at $568.7 million in 2022, then climbed by 2.04% to $580.3 million in 2023, then climbed by 16.57% to $676.5 million in 2024, then grew by 6.57% to $720.9 million in 2025, then rose by 2.15% to $736.4 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $736.4 million (Q1 2026), $720.9 million (Q4 2025), and $706.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 20.11 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 50.83 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 39.01 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 8.78 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 4.11 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 14.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 12.48 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 6.31 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 19.85 Bn
10 Warby Parker 3.11 Bn 2.82 Bn 131.04 Mn 736.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 736.41 Mn
Dec 31, 2025 720.92 Mn
Sep 30, 2025 706.92 Mn
Jun 30, 2025 701.90 Mn
Mar 31, 2025 682.76 Mn
Dec 31, 2024 676.49 Mn
Sep 30, 2024 637.99 Mn
Jun 30, 2024 618.21 Mn
Mar 31, 2024 592.89 Mn
Dec 31, 2023 580.31 Mn
Sep 30, 2023 574.88 Mn
Jun 30, 2023 561.71 Mn
Mar 31, 2023 557.88 Mn
Dec 31, 2022 568.71 Mn
Sep 30, 2022 550.15 Mn
Jun 30, 2022 543.56 Mn
Mar 31, 2022 544.67 Mn
Dec 31, 2021 440.65 Mn
Sep 30, 2021 459.56 Mn
Dec 31, 2020 444.75 Mn